Other chemokines potentially involved in cancer progression include CCL18, which promoted ovarian cancer migration (37), CCL20, which promoted both metastasis (38) and chemotherapy resistance (39), and CXCL8 (IL-8), which may contribute to peritoneal metastasis (40). Here, CCL18 is linked to ovarian carcinoma.